Earnings Feed
Start Free
Home/Filings/4/0001431373-11-000004
4//SEC Filing

Wilkinson Michael O. 4

Accession 0001431373-11-000004

CIK 0001003124other
View on SEC.govCompany Profile

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 3:38 PM ET

Size

20.0 KB

Accession

0001431373-11-000004

Insider Transaction Report

Form 4
Period: 2011-02-28
PHARMACEUTICAL PRODUCT DEVELOPMENT INCPPDI
Wilkinson Michael O.
Executive Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2011-02-28$20.45/sh+10,000$204,500→ 23,371 total
  • Sale

    Common Stock

    2011-02-28$28.19/sh−21,667$610,793→ 1,704 total
  • Exercise/Conversion

    Common Stock

    2011-02-28$25.74/sh+11,667$300,309→ 13,371 total
  • Exercise/Conversion

    Stock Options (to buy)

    2011-02-28−11,667→ 12,485 total
    Exercise: $25.74From: 2010-02-18Exp: 2019-02-18→ Common Stock (11,667 underlying)
  • Exercise/Conversion

    Stock Options (to buy)

    2011-02-28−10,000→ 21,052 total
    Exercise: $20.45From: 2011-02-25Exp: 2020-02-25→ Common Stock (10,000 underlying)
Holdings

  • Stock Options (to buy)

    Exercise: $43.26From: 2009-02-20Exp: 2018-02-20→ Common Stock (7,763 underlying)
    7,763

  • Stock Options (to buy)

    Exercise: $33.80From: 2008-09-27Exp: 2017-09-27→ Common Stock (62,104 underlying)
    62,104

  • Stock Options (to buy)

    Exercise: $26.64From: 2011-06-17Exp: 2020-06-17→ Common Stock (15,000 underlying)
    15,000

  • Stock Options (to buy)

    Exercise: $19.94From: 2009-11-20Exp: 2018-11-20→ Common Stock (12,421 underlying)
    6,211

  • Stock Options (to buy)

    Exercise: $37.69From: 2009-10-03Exp: 2018-10-03→ Common Stock (18,632 underlying)
    18,632
Footnotes (8)
  • [F1]The price shown is a weighted average; the shares were sold at prices ranging from $28.14 to $28.25. Upon request by the Commission staff, the issuer or a security holder, full information regarding the number of shares for each separate price is available.
  • [F2]The options vest in 1/3 increments on 2/18/10, 2/18/11 and 2/18/12.
  • [F3]The options vest in 1/3 increments on 2/25/11, 2/25/12 and 2/25/13.
  • [F4]The options vest in 1/3 increments on 6/17/11, 6/17/12 and 6/17/13.
  • [F5]The options vest in 1/3 increments on 11/20/09, 11/20/10 and 11/20/11.
  • [F6]The options will vest in 1/3 increments on 10/8/09, 10/8/10 and 10/8/11.
  • [F7]The options vest in 1/3 increments on 2/20/09, 2/20/10 and 2/20/11.
  • [F8]The options vest in 1/3 increments on 9/27/08, 9/27/09 and 9/27/10.

Documents

1 file

Issuer

PHARMACEUTICAL PRODUCT DEVELOPMENT INC

CIK 0001003124

→
Entity typeother

Related Parties

1
  • filerCIK 0001431373

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 3:38 PM ET
Size
20.0 KB
View on SEC.gov